Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat

Pain

Volumn 81, Issue 3, 1999, Pages 307-316

  Fox, Alyson ^a   Eastwood, Christopher ^a   Gentry, Clive ^a   Manning, Donald ^b   Urban, Laszlo ^a  

^a Novatis Inst for Medical Sciences   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Diabetes; Neuropathic pain; Partial ligation

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; BACLOFEN; DIZOCILPINE; INSULIN; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR ANTAGONIST; NITRIC OXIDE SYNTHASE INHIBITOR; STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; NERVE INJURY; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BACLOFEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HYPERALGESIA; INSULIN; MALE; MORPHINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; STREPTOZOCIN;

EID: 0033000028     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00024-X     Document Type: Article

References (62)

1. Ahlgren, S.C. and Levine, J.D., Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained, Brain Res., 616 (1993a) 171-175.
2. Ahlgren, S.C. and Levine, J.D., Mechanical hyperalgesia in streptozotocin-diabetic rats, Neuroscience, 52 (1993b) 1049-1055.
3. Ahlgren S.C., Wang J.F., Levine J.D. C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the rat. Neuroscience. 76:1997;285-290.
4. Ahlgren S.C., Levine J.D. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J. Neurophysiol. 72:1994;684-692.
5. Akunne, S.C. and Soliman, K.F., The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat, Psychopharmacology, 93 (1987) 167-172.
6. Babbedge C.R., Soper A.C., Gentry C.B., Hood V.G., Campbell E.A., Urban L. Characterization of peripheral afferent pathway of the rat in vitro after chronic sciatic nerve section in vivo. J. Neurophysiol. 76:1996;3169-3177.
7. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
8. Brown M.J., Sumner A.J., Greene D.A., Diamond S.M., Asbury A.K. Distal neuropathy in experimental diabetes mellitus. Ann. Neurol. 8:1980;168-178.
9. Burchiel K.J., Russell L.C., Lee R.P., Sima A.A. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats, a possible mechanism of chronic diabetic neuropathic pain. Diabetes. 34:1985;1210-1213.
10. Byas-Smith M.G., Max M.B., Muir J., Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage enriched enrollment design. Pain. 60:1995;267-274.
11. Calcutt N.A., Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122:1997;1478-1482.
12. Calcutt N.A., Jorge M.C., Yaksh T.L., Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain. 68:1996;293-299.
13. Calcutt N.A., Li L., Yaksh T.L., Malmberg A.B. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur. J. Pharmacol. 285:1995;189-197.
14. Calcutt N.A., Malmberg A.B., Yamamoto T., Yaksh T.L. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain. 58:1994;413-420.
15. Calissi P.T., Jaber L.A. Peripheral diabetic neuropathy: current concepts in treatment. Ann. Pharmacother. 29:1995;769-777.
16. Campbell E.A.C., Gentry C., Patel S., Panesar M.S., Walpole C.W., Urban L. Anti-hyperalgesic effects of NK1 receptor antagonists in a model of neuropathic pain in the guinea-pig. Neuroscience. 87:1998;527-532.
17. Castro-Lopez J.M., Malcangio M., Bowery N.G. Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res. 679:1995;289-297.
18. Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes. 35:1986;481-485.
19. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain. 57:1994;153-160.
20. Courteix C., Bardin M., Massol J., Fialip J., Lavarenne J., Eschalier A. Daily insulin treatment relieves long-term hyperalgesia in streptozocin diabetic rats. NeuroReport. 7:1996;1922-1924.
21. Courteix, C., Eschalier, A. and Lavarenne, J., Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, 53 (1993a) 81-88.
22. Courteix, C., Lavarenne, J. and Eschalier, A., RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats, Eur. J. Pharmacol., 241 (1993b) 267-270.
23. Diemel L.T., Stevens E.J., Willars G.B., Tomlinson D.R. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition. Neurosci. Lett. 137:1992;253-256.
24. Dyck P.J., Zimmerman B.R., Vilen T.H. Nerve glucose, sorbitol, myoinositol and fiber degeneration and regeneration in diabetic neuropathy. N. Engl. J. Med. 319:1988;542-548.
25. Forman L.J., Estilow S., Lewis M., Vasilenko P. Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 weeks in female rats. Diabetes. 35:1986;1309-1313.
26. Guilbaud G., Gautron M., Jazat F., Ratinahirana H., Hassig R., Hauw J.J. Time course of degeneration and regeneration of myelinated nerve fibres following chronic loose ligatures of the rat sciatic nerve: can nerve lesions be linked to the abnormal pain-related behaviours? Pain. 53:1993;147-158.
27. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32 (1988) 77-88.
28. Hellweg R., Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26:1990;258-267.
29. Hounson L., Tomlinson D.R. Does neuropathy develop in animal models? Clin. Neurosci. 4:1997;380-389.
30. Ibuki T., Hama A.T., Wang X.T., Pappas G.D., Sagen J. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience. 76:1997;845-858.
31. Kajander K.C., Bennett G.J. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J. Neurophysiol. 68:1992;734-744.
32. Kajander K.C., Xu J. Quantitative evaluation of calcitonin gene-related peptide and substance P levels in rat spinal cord following peripheral nerve injury. Neurosci. Lett. 186:1995;184-188.
33. Kajander K.C., Wakisaka S., Bennett G.J. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci. Lett. 138:1992;225-228.
34. Kunstyr I., Kupper W., Weisser H., Naumann S., Messow C. Urethral plug - a new secondary male sex characteristic in rat and other rodents. Lab. Animals. 16:1982;151-155.
35. Lee J.H., McCarty R. Glycemic control of pain threshold in diabetic and control rats. Physiol. Behav. 47:1990;225-230.
36. Lee J.H., McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain. 50:1992;231-236.
37. Longhurst, P.A., Kang, J., Wein, A.J. and Levin, R.M., The influence of intravesical volume upon contractile responses of the whole bladder preparation from streptozotocin-diabetic rats, Gen. Pharmacol., 21 (1990a) 687-692.
38. Longhurst, P.A., Kang, J., Wein, A.J. and Levin, R.M., Length-tension relationship of urinary bladder strips from streptozotocin-diabetic rats, Pharmacology, 40 (1990b) 110-121.
39. Malcangio M., Tomlinson D.R. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabteic rats. Pain. 76:1998;151-157.
40. Malmberg A.B., Yaksh T.L., Calcutt N.A. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci. Lett. 161:1993;45-48.
41. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
42. McQuay H., Carroll D., Jadad A., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. Br. Med. J. 311:1995;1047-1052.
43. Moss H.E., Lincoln J., Burnstock G. A study of bladder dysfunction during streptozotocin-induced diabetes in the rat using an in vitro whole bladder preparation. J. Urol. 138:1987;1279-1284.
44. Rakieten N., Rakieten L., Nadkarni M.V. Studies on the diabetogenic action of streptozotocin. Cancer Chemother. Rep. 29:1963;91.
45. Ramer M.S., Bisby M.A. Rapid sprouting of sympathetic axons in dorsal root ganglia of rats with a chronic constriction injury. Pain. 70:1997;237-244.
46. Raz I., Hasdai D., Seltzer Z., Melmed R.N. Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes. 37:1988;1253-1259.
47. Rittenhouse P.A., Marchand J.E., Chen J., Kream R.M., Leeman S.E. Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons. Peptides. 17:1996;1017-1022.
48. Seltzer Z., Dubner R., Shir Y. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
49. Sima, A.A., Nathaniel, V., Bril, V., McEwen, T.A. and Greene, D.A., Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy, J. Clin. Invest., 81 (1988) 349-364.
50. Sommer C., Lalonde A., Heckman H.M., Rodriguez M., Myers R.R. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J. Neuropathol. Exp. Neurol. 54:1995;635-643.
51. Thomas, P.K. and Scadding, J.W., Treatment of pain in diabetic neuropathy. In: P.J. Dyck, P.K. Thomas, A.K. Asbury, A.I. Winegrad, and D. Porter (Eds.), Diabetic Neuropathy, 1987 pp. 216-222.
52. Ueno Y., Koike H., Nakamura Y., Ochi Y., Annoh S., Nishio S. Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats. Jpn. J. Pharmacol. 70:1996;177-182.
53. Walker K., Dray A., Perkins M. Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 reecptor antagonist treatment. Pain. 65:1996;211-219.
54. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., Smith K.P., Maier S.F. Neurocircuitry of illnes-induced hyperalgesia. Brain Res. 634:1994;214-226.
55. Wegert S., Ossipov M.H., Nichols M.L., Bian D., Vanderah T.W., Malan T.P., Porreca F. Differential activities of intrathecal MK801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain. 71:1997;57-64.
56. Wright J.M. Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy. 14:1994;689-697.
57. Wuarin Bierman L., Zahnd G.R., Kaufmann F., Burcklen L., Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 30:1987;653-658.
58. Yagihashi, S., Kamijo, M. and Watanabe, K., Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats, Am. J. Pathol., 136 (1990a) 1365-1373.
59. Yagihashi, S., Kamijo, M., Ido, Y. and Mirrlees, D.J., Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy, Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats, Diabetes, 39 (1990b) 690-696.
60. Zeigler D., Lynch S.A., Muir J., Benjamin J., Max M.B. Transdermal clonidine versus placebo in painful diabetic neuropathy. Pain. 48:1992;403-408.
61. Zhuang H.X., Snyder C.K., Pu S.F., Ishii D.N. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp. Neurol. 140:1996;198-205.
62. Zochodne D.W., Murray M.M., van der Sloot P., Riopelle R.J. Distal tibial mononeuropathy in diabetic and nondiabetic rats reared on wire cages: an experimental entrapment neuropathy. Brain Res. 698:1995;130-136.